Cardiovascular Systems Top Insiders

Cardiovascular Systems' latest congressional trading

Cardiovascular Systems Management Team Effectiveness

The company has return on total asset (ROA) of (0.0756) % which means that it has lost $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1518) %, meaning that it created substantial loss on money invested by shareholders. Cardiovascular Systems' management efficiency ratios could be used to measure how well Cardiovascular Systems manages its routine affairs as well as how well it operates its assets and liabilities. Cardiovascular Systems holds a total of 42.2 Million outstanding shares. The majority of Cardiovascular Systems outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cardiovascular Systems to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cardiovascular Systems. Please pay attention to any change in the institutional holdings of Cardiovascular Systems as this could imply that something significant has changed or is about to change at the company. On April 19, 2023, Senator Tina Smith of US Senate acquired $50k to $100k worth of Cardiovascular Systems's common stock. Some institutional investors establish a significant position in stocks such as Cardiovascular Systems in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cardiovascular Systems, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Cardiovascular Systems Workforce Comparison

The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16.

Cardiovascular Systems Insider Trading

Cardiovascular Systems Notable Stakeholders

String symbol = request.getParameter("s");

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.